---

$1.76

+0.0050 ( +0.29% ) 0.1K

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-12-12	Sale	-703061.00	ARCH Venture Partners X, LLC
2023-12-12	Sale	-703061.00	Burow Kristina
2023-11-15	Buy	31653.00	ARCH Venture Partners XII, LLC
2023-11-15	Buy	31653.00	Burow Kristina
2023-11-13	Buy	69127.00	Burow Kristina
2023-11-13	Buy	69127.00	ARCH Venture Partners XII, LLC
2023-11-07	Buy	22420.00	Burow Kristina
2023-11-07	Buy	22420.00	ARCH Venture Partners XII, LLC
2023-09-29	Buy	16841.00	ARCH Venture Partners XII, LLC
2023-09-29	Buy	16841.00	Burow Kristina